163 related articles for article (PubMed ID: 28415681)
1. A reproducible model of intramedullary spinal cord tumor in rats bearing RG2 cells.
Zhuang Y; Zhao W; Zhang W; Wei H; Huang X; Cai G; Fu C; Wang C; Wang R; Shi S; Yang W; Chen C
Oncotarget; 2017 May; 8(19):30971-30977. PubMed ID: 28415681
[TBL] [Abstract][Full Text] [Related]
2. Microsurgical removal of intramedullary spinal cord gliomas in a rat spinal cord decreases onset to paresis, an animal model for intramedullary tumor treatment.
Pennant WA; Sciubba DM; Noggle JC; Tyler BM; Tamargo RJ; Jallo GI
Childs Nerv Syst; 2008 Aug; 24(8):901-7. PubMed ID: 18317780
[TBL] [Abstract][Full Text] [Related]
3. A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization.
Caplan J; Pradilla G; Hdeib A; Tyler BM; Legnani FG; Bagley CA; Brem H; Jallo G
Neurosurgery; 2006 Jul; 59(1):193-200; discussion 193-200. PubMed ID: 16823316
[TBL] [Abstract][Full Text] [Related]
4. Animal model of intramedullary spinal cord glioma using human glioblastoma multiforme neurospheres.
Hsu W; Siu IM; Pradilla G; Gokaslan ZL; Jallo GI; Gallia GL
J Neurosurg Spine; 2012 Mar; 16(3):315-9. PubMed ID: 22195609
[TBL] [Abstract][Full Text] [Related]
5. Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGel.
Tyler BM; Hdeib A; Caplan J; Legnani FG; Fowers KD; Brem H; Jallo G; Pradilla G
J Neurosurg Spine; 2012 Jan; 16(1):93-101. PubMed ID: 22208429
[TBL] [Abstract][Full Text] [Related]
6. A novel intramedullary spinal cord tumor model: functional, radiological, and histopathological characterization.
Mavinkurve G; Pradilla G; Legnani FG; Tyler BM; Bagley CA; Brem H; Jallo G
J Neurosurg Spine; 2005 Aug; 3(2):142-8. PubMed ID: 16370303
[TBL] [Abstract][Full Text] [Related]
7. Establishment of intramedullary spinal cord glioma model in rats.
Ren TJ; Wang ZC; Zhang YZ; Li D; Wang HY; Li ZZ
Chin Med J (Engl); 2010 Sep; 123(18):2580-5. PubMed ID: 21034632
[TBL] [Abstract][Full Text] [Related]
8. Combination Therapy by Tissue-Specific Suicide Gene and Bevacizumab in Intramedullary Spinal Cord Tumor.
Gwak SJ; Che L; Yun Y; Lee M; Ha Y
Yonsei Med J; 2020 Dec; 61(12):1042-1049. PubMed ID: 33251778
[TBL] [Abstract][Full Text] [Related]
9. A novel rodent model of spinal metastasis and spinal cord compression.
Zibly Z; Schlaff CD; Gordon I; Munasinghe J; Camphausen KA
BMC Neurosci; 2012 Nov; 13():137. PubMed ID: 23116234
[TBL] [Abstract][Full Text] [Related]
10. Lentiviral-Induced Spinal Cord Gliomas in Rat Model.
Nagarajan PP; Tora MS; Neill SG; Federici T; Texakalidis P; Donsante A; Canoll P; Lei K; Boulis NM
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884748
[TBL] [Abstract][Full Text] [Related]
11. Feasibility of a novel diagnostic chart of intramedullary spinal cord tumors in magnetic resonance imaging.
Arima H; Hasegawa T; Togawa D; Yamato Y; Kobayashi S; Yasuda T; Matsuyama Y
Spinal Cord; 2014 Oct; 52(10):769-73. PubMed ID: 25091110
[TBL] [Abstract][Full Text] [Related]
12. Effect of combined bevacizumab and temozolomide treatment on intramedullary spinal cord tumor.
Gwak SJ; An SS; Yang MS; Joe E; Kim DH; Yoon DH; Kim KN; Ha Y
Spine (Phila Pa 1976); 2014 Jan; 39(2):E65-73. PubMed ID: 24158177
[TBL] [Abstract][Full Text] [Related]
13. Surgical resection plus adjuvant radiotherapy is superior to surgery or radiotherapy alone in the prevention of neurological decline in a rat metastatic spinal tumor model.
Gok B; McGirt M; Sciubba DM; Ayhan S; Bydon A; Witham TF; Wolinsky JP; Gokaslan ZL
Neurosurgery; 2008 Aug; 63(2):346-51; discussion 351. PubMed ID: 18797365
[TBL] [Abstract][Full Text] [Related]
14. Effect of hyperglycemia on progressive paraparesis in a rat etastatic spinal tumor model.
McGirt MJ; Gok B; Shepherd S; Noggle J; Garcés Ambrossi GL; Bydon A; Gokaslan ZL
J Neurosurg Spine; 2009 Jan; 10(1):9-15. PubMed ID: 19119926
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic enlargement of the thecal sac volume by spinal expansion duroplasty in patients with unresectable malignant intramedullary tumors and metastases prior to radiotherapy.
Fiss I; Bettag C; Schatlo B; von Eckardstein K; Tsogkas I; Schwarz A; von der Brelie C; Rohde V
Neurosurg Rev; 2020 Feb; 43(1):273-279. PubMed ID: 30426355
[TBL] [Abstract][Full Text] [Related]
16. Radical microsurgical treatment of intramedullary spinal cord tumors.
Peng L; Qi ST; Chen Z; Fen WF; Fang LX; Huang LJ; Cheng JP
Chin Med J (Engl); 2006 Aug; 119(16):1343-7. PubMed ID: 16934179
[TBL] [Abstract][Full Text] [Related]
17. Spinal Cord Tumor Microenvironment.
Rauschenbach L
Adv Exp Med Biol; 2020; 1226():97-109. PubMed ID: 32030679
[TBL] [Abstract][Full Text] [Related]
18. Xenografting for disease modeling of intramedullary spinal cord tumors: a systematic review.
Rauschenbach L; Kocakavuk E; Pierscianek D; Ahmadipour Y; Kebir S; Glas M; Scheffler B; Sure U; Jabbarli R
Spinal Cord; 2019 Jun; 57(6):439-448. PubMed ID: 30710121
[TBL] [Abstract][Full Text] [Related]
19. The RG2 rat glioma model.
Aas AT; Brun A; Blennow C; Strömblad S; Salford LG
J Neurooncol; 1995; 23(3):175-83. PubMed ID: 7673979
[TBL] [Abstract][Full Text] [Related]
20. Fluorescein-Guided Resection of Intramedullary Spinal Cord Tumors: Results from a Preliminary, Multicentric, Retrospective Study.
Acerbi F; Cavallo C; Schebesch KM; Akçakaya MO; de Laurentis C; Hamamcioglu MK; Broggi M; Brawanski A; Falco J; Cordella R; Ferroli P; Kiris T; Höhne J
World Neurosurg; 2017 Dec; 108():603-609. PubMed ID: 28935546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
